RxDoctor Payments Data

Keri Clark, PA

Surgical · Highlands Ranch, CONPI 1043885890

Payments from drug & device makers

$1,345in general payments, 2019–2025

Across 29 payments — averaging $46.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Axonics, Inc.$236
  • Sumitomo Pharma America, Inc.$220
  • SRS Medical Systems, Inc.$167
  • Procept Biorobotics Corporation$159
  • AstraZeneca$155
  • Teleflex LLC$82
  • plus $326 from 7 others

What the payments were for

  • Food & beverage$1,345100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,345 in reported general payments places this provider in the 75th percentile of 495 surgical providers in Colorado.

See all surgical providers in Colorado

Medicare billing

Part B allowed, 2024
$67,632
Medicare patients
345
Services billed
713

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron58$66,718
GemtesaVibegron11$8,942
Methenamine Hippurate85$8,151
Tamsulosin Hcl274$4,268
Estradiol53$3,791
Oxybutynin Chloride ErOxybutynin Chloride84$2,237
Trospium Chloride24$1,495
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav23$1,163
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst39$653
Testosterone Cypionate21$647
Solifenacin Succinate12$600
Alfuzosin Hcl ErAlfuzosin Hcl19$470
Finasteride46$448
Cephalexin19$290
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim68$250

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Sumitomo Pharma America, Inc.Gemtesa$220$8,94211 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 495 surgical providers in Colorado.

Other surgical in Highlands Ranch

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →